Secrete, Capture, Sort, Sequence: NGS Decoded Molecular Recognition Pairs
分泌、捕获、排序、测序:NGS 解码的分子识别对
基本信息
- 批准号:10002308
- 负责人:
- 金额:$ 31.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAntibodiesBar CodesBindingBioinformaticsBiologicalBiological AssayBiological ModelsBiological ProcessBiologyCell SeparationCell surfaceCellsCleaved cellCloningClustered Regularly Interspaced Short Palindromic RepeatsCollectionColorComplexDNADNA SequenceDissociationDocumentationDyesElectron Transport Complex IIIExpenditureGenerationsGenetic DiseasesGenetic RecombinationGenotypeImmunoglobulin GIndividualKineticsLibrariesLinkMediatingMedicineMembrane ProteinsMethodsMonitorMonoclonal AntibodiesMusNeuronsOutputPartner in relationshipPatient Self-ReportPhenotypePlasmidsPopulationPopulation HeterogeneityProtein Binding DomainProtein IsoformsProteinsProxyRNA SplicingReagentRecombinant ProteinsRecombinantsReporterReportingReproducibilityResearchResourcesSpecific qualifier valueSpecificityStreptococcus pneumoniaeStructureSurfaceSynapsesSystemTechnologyTertiary Protein StructureTestingWorkYeastsbasecombinatorialcost estimatedesignflexibilityhigh throughput technologyhomologous recombinationinterestmembermolecular recognitionnanobodiesnext generation sequencingnovelpreservationprotein complexscaffoldscreeningtechnology developmentwasting
项目摘要
Despite the predominance of monoclonal antibody based technologies, the means by which monoclonal
antibodies are generated and disseminated, together with the size and structure of IgGs, impose fundamental
limitations on their usefulness, especially for research purposes. Poor specificity and documentation has led to
a crisis in experimental reproducibility, leading to an annual waste of ~$350 million in US research expenditures.
Rectifying this by the systematic generation of sequenced, validated monoclonals would cost an estimated
$50,000 per antibody and would fail for many targets.
Limitations of monoclonals will be addressed by developing a yeast `secrete and capture' co-display
system for the high throughput isolation and improvement of recombinant nonimmune Nanobodies (NBs), small
protein affinity reagents derived from camelid antibody VHH domains. Fluorogen-based FACS technology that
quantifies displayed NBs and captured target protein domains (TPDs) will be integrated with next generation
sequencing (NGS) that identifies the associated complex. Integration will greatly expand the repertoire of
biological targets for which cognate NBs may be isolated, and facilitate the creation of focused NB toolkits.
Current nonimmune scaffold screens use purified target protein to isolate candidate binders that are
physically cloned and individually evaluated. This resource-intensive approach will be replaced by the following:
(1) A FACS reporter assay that quantitatively reports the interaction of co-expressed NB and TPDs in
terms of specificity, affinity and kinetics, thus avoiding the use of purified protein. The assay is based on fusing
surface-displayed NBs and secreted TPDs to spectrally distinct fluorogen activating proteins (FAPs) that
fluoresce when binding non-fluorescent dyes (fluorogens); fluorogens may flexibly linked by PEG as a `tie-dye'.
A cleavable tie-dye is used to stabilize and report on a cell surface complex of secreted TPD and cognate
displayed NB; upon cleavage, kinetic analysis of TPD-FAP release from the cell surface allows one to estimate
NB/TPD affinity.
(2) A method that physically fuses the encoded genotypes of co-expressed NB and TPD, enabling NGS
analysis to resolve FACS assays of complex populations into the binding phenotypes of individual clones, thus
eliminating the need for physical cloning. After mass mating of yeast libraries respectively encoding NBs and
secreted TPDs on separate plasmids, CRISPR will be used to force bulk recombination of sequences encoding
the NB and a barcode that identifies the associated TPD into a single NGS decodable read frame.
(3) Multiplexed screens in the form of bioinformatics derived TPD query sets to directly obtain groups of
related reagents, thus minimizing the need to serially evaluate individual clones. Queries will be used to isolate
NBs that probe biological functionalities that were previously very difficult to approach; our test cases will be: (i)
neuroligin splice isoforms; (ii) neuroligin/neurexin complexes; and (iii) bacterial surface protein ectodomains.
尽管基于单克隆抗体的技术占主导地位,但单克隆抗体的方法仍然存在。
抗体的产生和传播,以及IgG的大小和结构,
其用途有限,特别是用于研究目的。缺乏特异性和文件记录导致
实验再现性的危机,导致美国每年浪费约3.5亿美元的研究经费。
通过系统地产生测序的、经验证的单克隆抗体来纠正这一点,
每种抗体5万美元,对许多靶标都无效。
单克隆抗体的局限性将通过开发酵母“分泌和捕获”共展示来解决
用于重组非免疫纳米抗体(NB)的高通量分离和改进的系统,
衍生自骆驼科动物抗体VHH结构域的蛋白质亲和试剂。基于荧光的FACS技术,
定量展示的NB和捕获的靶蛋白结构域(TPD)将与下一代整合,
测序(NGS),其鉴定相关复合物。整合将极大地扩展
生物靶标,可以针对其分离同源NB,并促进创建聚焦NB工具包。
目前的非免疫支架筛选使用纯化的靶蛋白来分离候选结合物,
物理克隆和单独评估。这一资源密集型办法将由以下办法取代:
(1)流式细胞仪报告分析,定量报告共表达的NB和TPD的相互作用,
根据特异性、亲和性和动力学,从而避免使用纯化的蛋白质。该分析基于融合
将表面展示的NB和分泌的TPD转化为光谱上不同的荧光团激活蛋白(FAP),
当结合非荧光染料(荧光团)时发出荧光;荧光团可以通过PEG作为“扎染剂”灵活地连接。
可裂解的扎染剂用于稳定和报道分泌的TPD和同源物的细胞表面复合物,
在裂解后,从细胞表面释放TPD-FAP的动力学分析允许人们估计
NB/TPD亲和力。
(2)一种物理融合共表达的NB和TPD的编码基因型的方法,
分析以将复杂群体的FACS测定解析为单个克隆的结合表型,因此
消除了物理克隆的需要。在分别编码NB和NB的酵母文库的大量交配后,
为了在单独的质粒上产生分泌的TPD,CRISPR将用于迫使编码以下的序列的大量重组:
NB和识别相关联的TPD的条形码到单个NGS可解码的读帧中。
(3)以生物信息学衍生的TPD查询集的形式进行多重筛选,以直接获得多组
相关试剂,从而最大限度地减少了连续评估单个克隆的需要。将使用隔离器隔离
NB探测以前很难接近的生物功能;我们的测试用例将是:(i)
神经连接蛋白剪接同种型;(ii)神经连接蛋白/神经连接蛋白复合物;和(iii)细菌表面蛋白胞外域。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bottom-Up Design: A Modular Golden Gate Assembly Platform of Yeast Plasmids for Simultaneous Secretion and Surface Display of Distinct FAP Fusion Proteins.
自下而上的设计:酵母质粒的模块化金门组装平台,用于同时分泌和表面展示不同的 FAP 融合蛋白。
- DOI:10.1021/acssynbio.2c00283
- 发表时间:2022
- 期刊:
- 影响因子:4.7
- 作者:Szent-Gyorgyi,Christopher;Perkins,LydiaA;Schmidt,BrigitteF;Liu,Zhen;Bruchez,MarcelP;vandeWeerd,Robert
- 通讯作者:vandeWeerd,Robert
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marcel P Bruchez其他文献
Marcel P Bruchez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marcel P Bruchez', 18)}}的其他基金
A Confocal Fluorescence Microscopy Brain Data Archive
共焦荧光显微镜脑数据档案
- 批准号:
10186823 - 财政年份:2017
- 资助金额:
$ 31.62万 - 项目类别:
A Confocal Fluorescence Microscopy Brain Data Archive
共焦荧光显微镜脑数据档案
- 批准号:
10451277 - 财政年份:2017
- 资助金额:
$ 31.62万 - 项目类别:
A Confocal Fluorescence Microscopy Brain Data Archive
共焦荧光显微镜脑数据档案
- 批准号:
10651779 - 财政年份:2017
- 资助金额:
$ 31.62万 - 项目类别:
Secrete, Capture, Sort, Sequence: NGS Decoded Molecular Recognition Pairs
分泌、捕获、排序、测序:NGS 解码的分子识别对
- 批准号:
9566258 - 财政年份:2017
- 资助金额:
$ 31.62万 - 项目类别:
Secrete, Capture, Sort, Sequence: NGS Decoded Molecular Recognition Pairs
分泌、捕获、排序、测序:NGS 解码的分子识别对
- 批准号:
9467841 - 财政年份:2017
- 资助金额:
$ 31.62万 - 项目类别:
Fluorogen Activating Peptide-Based FRET to Quantify FceRI Activation Mechanisms
基于荧光激活肽的 FRET 来量化 FceRI 激活机制
- 批准号:
9041634 - 财政年份:2015
- 资助金额:
$ 31.62万 - 项目类别:
Targeted fluorescent indicators for endothelial physiology: Ca(II), ROS, NO
内皮生理学靶向荧光指标:Ca(II)、ROS、NO
- 批准号:
8865632 - 财政年份:2013
- 资助金额:
$ 31.62万 - 项目类别:
Targeted fluorescent indicators for endothelial physiology: Ca(II), ROS, NO
内皮生理学靶向荧光指标:Ca(II)、ROS、NO
- 批准号:
8698418 - 财政年份:2013
- 资助金额:
$ 31.62万 - 项目类别:
Targeted fluorescent indicators for endothelial physiology: Ca(II), ROS, NO
内皮生理学靶向荧光指标:Ca(II)、ROS、NO
- 批准号:
8562575 - 财政年份:2013
- 资助金额:
$ 31.62万 - 项目类别:
Bright Blinking Probes for Fast Multicolor Superresolution Imaging in Live Cells
用于活细胞中快速多色超分辨率成像的明亮闪烁探头
- 批准号:
7943995 - 财政年份:2009
- 资助金额:
$ 31.62万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 31.62万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 31.62万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 31.62万 - 项目类别: